Written and maintained by CASRAI Editorial Board
Published
On this page
The hallmarks of aging are a published framework that lists the cellular and molecular features that characterise aging and that researchers can test one at a time. López-Otín and colleagues proposed nine in Cell in 2013 and expanded the list to twelve in Cell in 2023, adding disabled macroautophagy, chronic inflammation and dysbiosis. A feature earns a place by meeting three premises: it appears with age, worsening it speeds aging, and correcting it can slow aging.
Definition and scope
The 2013 paper, “The Hallmarks of Aging” (López-Otín, Blasco, Partridge, Serrano and Kroemer, Cell 153(6):1194-1217), set out to “enumerate” the common denominators of aging in different organisms, concentrating on mammals. It called its nine items “tentative” hallmarks. The 2023 update, “Hallmarks of aging: An expanding universe” (Cell 186(2):243-278), by the same five authors, keeps the concept and widens the list to twelve. The framework is a classification used to organise hypotheses and experiments. It is not a diagnostic test, a biological age score or a treatment protocol, and it does not tell a lab which assay to run.
For the wider field in which these hallmarks are used, including the geroscience hypothesis that targeting aging biology may delay several age-related diseases together, see the CASRAI guide to geroscience. That guide covers the seven pillars of aging; this page covers the separate hallmarks framework.
How the hallmarks are defined and tested
The 2013 paper gave three criteria that an aging hallmark should ideally satisfy: (i) it should manifest during normal aging; (ii) its experimental aggravation should accelerate aging; and (iii) its experimental amelioration should retard the normal aging process and, hence, increase healthy lifespan. The authors described the third criterion as the most difficult to achieve and said the nine hallmarks meet the criteria “to varying degrees”. The 2023 abstract restates the idea as three premises: age-associated manifestation, acceleration of aging by experimentally accentuating the hallmark, and the opportunity to decelerate, stop or reverse aging by therapeutic intervention on it.
The table below puts the two formulations side by side.
| Test | 2013 wording (nine hallmarks) | 2023 wording (twelve hallmarks) |
|---|---|---|
| Does it appear with age? | Manifests during normal aging | Age-associated manifestation |
| Does making it worse speed aging? | Experimental aggravation accelerates aging | Aging is accelerated by experimentally accentuating it |
| Does correcting it help? | Experimental amelioration retards normal aging and increases healthy lifespan | Opportunity to decelerate, stop or reverse aging by therapeutic interventions on it |
The practical consequence is that a hallmark is a claim with graded evidence. In the 2013 text, telomere attrition is the clearest case: experimental stimulation of telomerase delays aging in mice, which the authors said fulfils all of the criteria. Histone methylation is described as meeting the criteria in invertebrates, where deleting components of histone methylation complexes extends longevity in nematodes and flies; the same passage says it is not yet clear whether histone-modifying enzymes influence aging through purely epigenetic mechanisms. Other hallmarks are supported mainly by the first two criteria. When you read a paper that invokes a hallmark, check which of the three has actually been shown, in which organism.
The 9 original and 12 current hallmarks
The data table below this guide lists all twelve hallmarks, whether each appeared in the 2013 or 2023 list, its 2013 category, and one example of evidence that the 2013 paper itself cites. It was compiled only from the two Cell papers and is available as CSV or JSON. The sections below describe each hallmark as the 2013 paper does.
Genomic instability
The 2013 paper describes the accumulation of genetic damage throughout life as a common denominator of aging. Damage arises from external agents and from internal threats such as replication errors, spontaneous hydrolytic reactions and reactive oxygen species, and includes point mutations, translocations, chromosomal gains and losses, and telomere shortening. Causal evidence comes from DNA repair deficiencies, which cause accelerated aging in mice and underlie human progeroid syndromes such as Werner and Bloom syndromes. In the other direction, transgenic mice overexpressing BubR1, a mitotic checkpoint component, showed protection against aneuploidy and cancer and extended healthy lifespan. The authors also note that progeroid syndromes recapitulate only some aspects of aging, so their relevance to normal aging remains unresolved.
Telomere attrition
Most mammalian somatic cells do not express telomerase, so the ends of chromosomes lose protective sequence progressively. The paper links this to the limited proliferative capacity of cultured cells (replicative senescence, or the Hayflick limit) and notes that telomere shortening is also seen in normal aging in humans and mice.
Epigenetic alterations
Changes in DNA methylation, histone modification and chromatin remodelling occur across tissues. The paper lists age-associated marks such as increased H4K16 acetylation and decreased H3K9 methylation, and uses SIRT6 as an example: loss of function reduces longevity in mice and gain of function extends it. For the lab methods that deliberately reset these marks, see the CASRAI guide to epigenetic reprogramming.
Loss of proteostasis
Aging and some aging-related diseases are linked to impaired protein homeostasis. Proteostasis combines the stabilisation of correctly folded proteins, chiefly heat-shock proteins, with degradation by the proteasome or the lysosome. The 2013 text discusses macroautophagy inside this section, for example through the lifespan effects of rapamycin and spermidine in model organisms; in the 2023 list it becomes a hallmark of its own.
Deregulated nutrient sensing
The growth hormone and insulin/IGF-1 signalling (IIS) pathway is described as the most conserved aging-controlling pathway in evolution, with targets including FOXO transcription factors and the mTOR complexes. Mutations or polymorphisms that reduce GH, IGF-1 receptor, insulin receptor, AKT, mTOR or FOXO function have been linked to longevity in humans and model organisms.
Mitochondrial dysfunction
The efficacy of the respiratory chain tends to diminish with age, increasing electron leakage and reducing ATP generation. The mitochondrial free radical theory proposed that this raises reactive oxygen species (ROS) and causes further damage, but the paper says recent work forced an “intense re-evaluation”: increased ROS can prolong lifespan in yeast and C. elegans. That is why the paper places ROS in its antagonistic category. For the organelle biology, see mitochondria and function.
Cellular senescence
Senescence is defined as a stable arrest of the cell cycle with stereotyped phenotypic changes, first described by Hayflick in cultured human fibroblasts. Telomere shortening, non-telomeric DNA damage and de-repression of the INK4/ARF locus can all trigger it. The paper cites a study using senescence-associated β-galactosidase and DNA damage in mouse liver that found about 8% senescent cells in young mice and about 17% in very old mice. It argues senescence may originally be a beneficial response that removes damaged cells, which becomes harmful when clearance and replacement fail.
Stem cell exhaustion
Declining regenerative potential is described as one of the most obvious characteristics of aging. Haematopoiesis declines with age, and similar attrition is found in other adult stem cell compartments. Parabiosis experiments showed that the decline in neural and muscle stem cell function in old mice can be reversed by systemic factors from young mice, which the paper uses to argue that cell-extrinsic factors matter.
Altered intercellular communication
Beyond cell-autonomous changes, aging involves endocrine, neuroendocrine and neuronal signalling changes. The paper highlights “inflammaging”, a smouldering pro-inflammatory phenotype in aging mammals, within this hallmark. In the 2023 list, chronic inflammation is separated out.
The three additions in 2023
Comparing the two abstracts, the 2023 list adds disabled macroautophagy, chronic inflammation and dysbiosis. The 2023 abstract also says the hallmarks are interconnected with each other and with the recently proposed “hallmarks of health”: spatial compartmentalisation, maintenance of homeostasis and adequate responses to stress. The Spanish National Cancer Research Centre (CNIO), where co-author María A. Blasco worked, described the update as expanding the hallmarks “from nine to twelve” and each hallmark as a point of entry for future exploration of aging.
Primary, antagonistic and integrative hallmarks
The 2013 paper sorted its nine hallmarks into three groups, and this grouping is the part most summaries leave out.
- Primary hallmarks are unequivocally negative: DNA damage (including aneuploidy and mitochondrial DNA mutations), telomere loss, epigenetic drift and defective proteostasis.
- Antagonistic hallmarks have opposite effects depending on intensity. Senescence protects against cancer but in excess promotes aging; ROS supports signalling and survival but at chronic high levels causes damage; nutrient sensing and anabolism are needed for survival but become pathological in excess over time.
- Integrative hallmarks are stem cell exhaustion and altered intercellular communication. They directly affect tissue homeostasis and function.
The authors proposed a hierarchy: primary hallmarks act as initiating triggers, antagonistic hallmarks respond to them and turn negative when exacerbated or chronic, and integrative hallmarks arise when the accumulated damage can no longer be compensated by tissue homeostasis. They also called the causal network among hallmarks an open challenge. The category assignments are those of the 2013 paper; the three 2023 additions have no 2013 category in the sources used here.
Where it matters for labs
For a lab or a research office, the framework matters in four concrete ways.
- Aims and hypotheses. A grant or manuscript that says it targets a hallmark can be checked against the three premises: which has been shown, and in which organism or cell type?
- Choosing readouts. The framework does not prescribe assays. The 2013 paper itself shows why: senescent cells were inferred in tissue from surrogate markers such as DNA damage, and in some studies counted directly with senescence-associated β-galactosidase, giving comparable numbers in the liver study it cites. State which readout supports which hallmark claim.
- Interpreting interventions. Rapamycin appears in the 2013 text under proteostasis, nutrient sensing and stem cell function. One intervention touching several hallmarks is expected given their interconnection, so attribute effects cautiously.
- Finding a venue. Aging-biology work is published in specialist journals; see the guide to npj Aging. Funding for aging research in the United States runs through the National Institute on Aging.
Common misunderstandings
- “The hallmarks are the seven pillars.” They are different frameworks. The hallmarks list cellular and molecular features of aging; the geroscience pillars are covered separately in the geroscience guide.
- “There are nine hallmarks.” That is the 2013 list. The 2023 paper by the same authors lists twelve.
- “All hallmarks are proven drivers of aging.” The 2013 paper says they meet its criteria to varying degrees and calls them tentative; the third criterion is the hardest.
- “A hallmark is always harmful.” Antagonistic hallmarks such as senescence and ROS signalling have beneficial roles at low levels.
- “Each hallmark acts independently.” Both papers describe them as interconnected.
FAQ
What are the hallmarks of aging?
They are a set of cellular and molecular features proposed in Cell as common denominators of aging. The 2013 list has nine; the 2023 update has twelve.
What are the 12 hallmarks of aging?
Genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient-sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation and dysbiosis.
What is new in the 2023 update?
Disabled macroautophagy, chronic inflammation and dysbiosis were added to the original nine, and the paper links the hallmarks to the hallmarks of health.
What criteria must a hallmark meet?
It should appear with normal aging, its experimental aggravation should accelerate aging, and its experimental amelioration should slow aging and increase healthy lifespan.
Are the hallmarks a test of biological age?
No. In the sources read for this page, the hallmarks are a conceptual framework for organising mechanisms, not a measurement of an individual’s age or health. This page gives no medical advice.
Sources
- López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The Hallmarks of Aging. Cell 2013;153(6):1194-1217. PMID 23746838. PubMed Central full text, read 2026-11-12.
- López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell 2023;186(2):243-278. doi:10.1016/j.cell.2022.11.001. PubMed abstract, read 2026-11-12.
- CNIO. News release, 10 January 2023, on the Cell review by María A. Blasco and colleagues. cnio.es, read 2026-11-12.
Data: The 2013 nine and 2023 twelve hallmarks of aging: list membership, 2013 category and cited evidence
Crosswalk of the nine hallmarks proposed in Cell 2013 and the twelve in Cell 2023, built from the 2013 full text and the 2023 abstract: whether each appears in each list, its 2013 category (primary, antagonistic, integrative) and one example of evidence cited in the 2013 paper.
Period covered: 2013/2023.
| Hallmark | In 2013 list (nine) | In 2023 list (twelve) | 2013 category | Example of evidence cited in 2013 paper |
|---|---|---|---|---|
| Genomic instability | Yes | Yes | Primary | DNA repair deficiencies cause accelerated aging in mice; BubR1 overexpression extended healthy lifespan in mice |
| Telomere attrition | Yes | Yes | Primary | Experimental telomerase stimulation delays aging in mice |
| Epigenetic alterations | Yes | Yes | Primary | SIRT6 loss of function reduces longevity and gain of function extends it in mice |
| Loss of proteostasis | Yes | Yes | Primary | Enhanced proteasome activity extends replicative lifespan in yeast |
| Disabled macroautophagy | No | Yes | Not a separate hallmark in 2013 (macroautophagy discussed under proteostasis) | Not assessed as a separate hallmark in the 2013 paper |
| Deregulated nutrient-sensing | Yes | Yes | Antagonistic | Reduced function of GH, IGF-1 receptor, insulin receptor, AKT, mTOR or FOXO linked to longevity in humans and model organisms |
| Mitochondrial dysfunction | Yes | Yes | Antagonistic (ROS) | Increased ROS can prolong lifespan in yeast and C. elegans |
| Cellular senescence | Yes | Yes | Antagonistic | About 8% senescent cells in young and about 17% in very old mouse liver in a cited study |
| Stem cell exhaustion | Yes | Yes | Integrative | Young systemic factors reversed neural and muscle stem cell decline in old mice (parabiosis) |
| Altered intercellular communication | Yes | Yes | Integrative | Inflammaging described as a prominent age-associated alteration |
| Chronic inflammation | No | Yes | Not a separate hallmark in 2013 (inflammaging discussed under intercellular communication) | Not assessed as a separate hallmark in the 2013 paper |
| Dysbiosis | No | Yes | Not in the 2013 list | Not assessed in the 2013 paper |
Sources
- The Hallmarks of Aging, Cell 2013 (accessed 2026-11-12)
- Hallmarks of aging: An expanding universe, Cell 2023 (PubMed abstract) (accessed 2026-11-12)
Compiled by CASRAI from the sources above. Free to reuse under CC BY 4.0 with attribution.







